Angela M. Andrews, Cynthia L. Russell, Steven Chesnut
{"title":"在一项成人肾移植受者随机对照试验中,SystemCHANGETM干预对系统思维的影响:二次数据分析","authors":"Angela M. Andrews, Cynthia L. Russell, Steven Chesnut","doi":"10.5993/ajhb.47.4.16","DOIUrl":null,"url":null,"abstract":"Objective: The SystemCHANGE™ intervention is an approach that harnesses patients′ recurring personal systems of established routines of daily living, environments, and important others as reliable ′personalized system solutions′ to support habitual medication-taking and improve medication adherence. In a secondary data analysis, we (1) analyzed the association between the longitudinal trajectories of systems thinking and medication adherence, and (2) examined the extent that demographic characteristics and the SystemCHANGE™ intervention influenced these trajectories. Methods: Participants were ≥ 18 years of age who had received a kidney‐only transplant, self‐administered at least one prescribed immunosuppressive medication twice daily, had a functioning kidney transplant, were not in the hospital, and had no diagnosis that would immediately shorten the lifespan. We conducted a single‐blinded (participants), 2‐arm randomized controlled trial (RCT). An intervention group received the 6-month SystemCHANGETM intervention, and the attention-control group received the 6-month education intervention. Systems thinking was measured using the Systems Thinking Scale (adapted for patients). Results: The parallel process growth curve model with time-invariant predictors suggested that participants with higher levels of systems thinking at baseline demonstrated greater gains in systems thinking over time (r=0.407). White participants exhibited greater baseline levels of systems thinking than African-American participants (d=0.76). Participants assigned to the SystemCHANGE™ group maintained their medication adherence rates over time, whereas control counterparts demonstrated significantly different, declining trajectories of medication adherence (d=−0.41). Conclusion: We found shared co-variance between systems thinking and medication adherence and the SystemCHANGE™ intervention. The SystemCHANGE™ intervention was efficacious in improving and sustaining medication adherence in adult kidney transplant recipients.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Effect of the SystemCHANGETM Intervention on Systems Thinking in a Randomized Controlled Trial of Adult Kidney Transplant Recipients: A Secondary Data Analysis\",\"authors\":\"Angela M. Andrews, Cynthia L. Russell, Steven Chesnut\",\"doi\":\"10.5993/ajhb.47.4.16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The SystemCHANGE™ intervention is an approach that harnesses patients′ recurring personal systems of established routines of daily living, environments, and important others as reliable ′personalized system solutions′ to support habitual medication-taking and improve medication adherence. In a secondary data analysis, we (1) analyzed the association between the longitudinal trajectories of systems thinking and medication adherence, and (2) examined the extent that demographic characteristics and the SystemCHANGE™ intervention influenced these trajectories. Methods: Participants were ≥ 18 years of age who had received a kidney‐only transplant, self‐administered at least one prescribed immunosuppressive medication twice daily, had a functioning kidney transplant, were not in the hospital, and had no diagnosis that would immediately shorten the lifespan. We conducted a single‐blinded (participants), 2‐arm randomized controlled trial (RCT). An intervention group received the 6-month SystemCHANGETM intervention, and the attention-control group received the 6-month education intervention. Systems thinking was measured using the Systems Thinking Scale (adapted for patients). Results: The parallel process growth curve model with time-invariant predictors suggested that participants with higher levels of systems thinking at baseline demonstrated greater gains in systems thinking over time (r=0.407). White participants exhibited greater baseline levels of systems thinking than African-American participants (d=0.76). Participants assigned to the SystemCHANGE™ group maintained their medication adherence rates over time, whereas control counterparts demonstrated significantly different, declining trajectories of medication adherence (d=−0.41). Conclusion: We found shared co-variance between systems thinking and medication adherence and the SystemCHANGE™ intervention. The SystemCHANGE™ intervention was efficacious in improving and sustaining medication adherence in adult kidney transplant recipients.\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2023-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5993/ajhb.47.4.16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5993/ajhb.47.4.16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
The Effect of the SystemCHANGETM Intervention on Systems Thinking in a Randomized Controlled Trial of Adult Kidney Transplant Recipients: A Secondary Data Analysis
Objective: The SystemCHANGE™ intervention is an approach that harnesses patients′ recurring personal systems of established routines of daily living, environments, and important others as reliable ′personalized system solutions′ to support habitual medication-taking and improve medication adherence. In a secondary data analysis, we (1) analyzed the association between the longitudinal trajectories of systems thinking and medication adherence, and (2) examined the extent that demographic characteristics and the SystemCHANGE™ intervention influenced these trajectories. Methods: Participants were ≥ 18 years of age who had received a kidney‐only transplant, self‐administered at least one prescribed immunosuppressive medication twice daily, had a functioning kidney transplant, were not in the hospital, and had no diagnosis that would immediately shorten the lifespan. We conducted a single‐blinded (participants), 2‐arm randomized controlled trial (RCT). An intervention group received the 6-month SystemCHANGETM intervention, and the attention-control group received the 6-month education intervention. Systems thinking was measured using the Systems Thinking Scale (adapted for patients). Results: The parallel process growth curve model with time-invariant predictors suggested that participants with higher levels of systems thinking at baseline demonstrated greater gains in systems thinking over time (r=0.407). White participants exhibited greater baseline levels of systems thinking than African-American participants (d=0.76). Participants assigned to the SystemCHANGE™ group maintained their medication adherence rates over time, whereas control counterparts demonstrated significantly different, declining trajectories of medication adherence (d=−0.41). Conclusion: We found shared co-variance between systems thinking and medication adherence and the SystemCHANGE™ intervention. The SystemCHANGE™ intervention was efficacious in improving and sustaining medication adherence in adult kidney transplant recipients.